نتائج البحث - Jan Trka
- يعرض 1 - 20 نتائج من 44
- اذهب إلى الاصفحة التالية
-
1
-
2
Detection of prognostically relevant genetic abnormalities in childhood B‐cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of... حسب Christine J. Harrison, Oskar A. Haas, Jochen Harbott, Andrea Biondi, Martin Stanulla, Jan Trka, Shai Izraeli
منشور في 2010Revisão -
3
ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia حسب Jan Zuna, Jozef Madžo, Ondřej Krejčí, Zuzana Zemanová, Markéta Kalinová, Kateřina Mužíková, Michal Zápotocký, Júlia Starková, Ondřej Hrušák, Jiří Horák, Jan Trka
منشور في 2011Carta -
4
Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cy... حسب Jan Trka, Markéta Kalinová, O Hrušák, Jan Zuna, Ondřej Krejčí, Jozef Madžo, Petr Sedláček, V. Vávra, K Michalová, Marie Jarošová, Jan Starý
منشور في 2002Artigo -
5
<i>ERG</i> deletions in childhood acute lymphoblastic leukemia with <i>DUX4</i> rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depe... حسب Markéta Žaliová, Eliška Potůčková, Lenka Hovorková, Alena Musilová, Lucie Winkowska, Karel Fišer, Jan Stuchlý, Ester Mejstříková, Júlia Starková, Jan Zuna, Jan Starý, Jan Trka
منشور في 2019Artigo -
6
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort حسب Markéta Žaliová, Jan Stuchlý, Lucie Winkowska, Alena Musilová, Karel Fišer, Martina Slámová, Júlia Starková, Martina Vášková, Ondřej Hrušák, Lucie Šrámková, Jan Starý, Jan Zuna, Jan Trka
منشور في 2019Artigo -
7
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53 حسب N. E. Gefen, Vera Binder, Markéta Žaliová, Yvonne Linka, Michelle Morrow, Astrid Novosel, Liat Edry, Libi Hertzberg, Noam Shomron, Owen Williams, Jan Trka, Arndt Borkhardt, Shai Izraeli
منشور في 2009Artigo -
8
Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL حسب Michaela Kotrová, Vincent H. J. van der Velden, Jacques J. M. van Dongen, Renata Formánková, Petr Sedláček, Monika Brüggemann, Jan Zuna, Jan Starý, Jan Trka, Eva Froňková
منشور في 2017Artigo -
9
Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clini... حسب Nikola Hagedorn, Cécile Acquaviva, Eva Froňková, Arend von Stackelberg, Andrea Barth, Udo zur Stadt, André Schrauder, Jan Trka, Nathalie Gaspar, Karl Seeger, Günter Henze, Hélène Cavé, Cornelia Eckert
منشور في 2007Artigo -
10
The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL حسب Michaela Kotrová, Kateřina Mužíková, Ester Mejstříková, Michaela Nováková, Violeta Bakardjieva-Mihaylova, Karel Fišer, Jan Stuchlý, Mathieu Giraud, Mikaël Salson, Christiane Pott, Monika Brüggemann, Marc Füllgrabe, Jan Starý, Jan Trka, Eva Froňková
منشور في 2015Carta -
11
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia حسب Jasmijn de Rooij, Eva Beuling, Marry M. van den Heuvel‐Eibrink, Askar Obulkasim, André Baruchel, Jan Trka, Dirk Reinhardt, Edwin Sonneveld, B Gibson, Rob Pieters, M Zimmermann, C. Michel Zwaan, Maarten Fornerod
منشور في 2015Artigo -
12
NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol حسب Michael Svatoň, Aneta Skotnicová, Leona Reznickova, Andrea Rennerova, Tatana Valova, Michaela Kotrová, Vincent H. J. van der Velden, Monika Brüggemann, Nikos Darzentas, Anton W. Langerak, Jan Zuna, Jan Starý, Jan Trka, Eva Froňková
منشور في 2022Artigo -
13
NGS‐MRD negativity in post‐HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse risk حسب Krystof Seferna, Michael Svatoň, Andrea Rennerova, Aneta Skotnicová, Leona Reznickova, Tatana Valova, Petr Sedláček, Petr Říha, Renata Formánková, Petra Keslová, Lucie Šrámková, Jan Starý, Jan Zuna, Alexandra Kolenová, Cyril Šálek, Jan Trka, Eva Fronkova
منشور في 2025Artigo -
14
BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations حسب Anindita Basak, Miroslava Hančárová, Jacob C. Ulirsch, Tuğçe B. Balcı, Marie Trková, Michal Pelisek, Markéta Vlčková, Kateřina Mužíková, Jaroslav Čermák, Jan Trka, David A. Dyment, Stuart H. Orkin, Mark J. Daly, Zdeněk Sedláček, Vijay G. Sankaran
منشور في 2015Artigo -
15
Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing? حسب Eva Froňková, Ester Mejstříková, Smadar Avigad, Ki Wai Chik, Luis Castillo, Sigal Manor, Leona Reznickova, Tatana Valova, Kateřina Zdráhalová, Ondřej Hrušák, Y. Jabali, Martin Schrappe, Valentino Conter, Shai Izraeli, Chi Kong Li, Batia Stark, Jan Starý, Jan Trka
منشور في 2008Artigo -
16
<i>DUX4r</i>, <i>ZNF384r</i> and <i>PAX5</i>-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch حسب Michaela Nováková, Markéta Žaliová, Karel Fišer, Barbora Vakrmanová, Lucie Slámová, Alena Musilová, Monika Brüggemann, Matthias Ritgen, Eva Froňková, Tomáš Kalina, Jan Starý, Lucie Winkowska, Peter Švec, Alexandra Kolenová, Jan Stuchlý, Jan Zuna, Jan Trka, Ondřej Hrušák, Ester Mejstříková
منشور في 2020Artigo -
17
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study حسب André Willasch, Bernd Gruhn, Tiziana Coliva, Markéta Kalinová, Gisbert Schneider, Hermann Kreyenberg, Daniel Steinbach, Gerrit Weber, Iris H.I.M. Hollink, C. Michel Zwaan, Andrea Biondi, Vincent H. J. van der Velden, Dirk Reinhardt, Giovanni Cazzaniga, Peter Bader, Jan Trka
منشور في 2009Artigo -
18
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study حسب Jasmijn de Rooij, Riccardo Masetti, Marry M. van den Heuvel‐Eibrink, Jean-Michel Cayuela, Jan Trka, Dirk Reinhardt, Mareike Rasche, Edwin Sonneveld, Todd A. Alonzo, Maarten Fornerod, Martin Zimmermann, Martina Pigazzi, Rob Pieters, Soheil Meshinchi, C. Michel Zwaan, Franco Locatelli
منشور في 2016Artigo -
19
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology حسب Lenka Hovorková, Markéta Žaliová, Nicola C. Venn, Kirsten Bleckmann, Marie Trková, Eliška Potůčková, Martina Vášková, Jana Linhartová, Kateřina Machová Poláková, Eva Froňková, Walter Muskovic, Jodie E. Giles, Peter J. Shaw, Gunnar Cario, Rosemary Sutton, Jan Starý, Jan Trka, Jan Zuna
منشور في 2017Artigo -
20
Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria حسب Ester Mejstříková, Jana Volejníková, Eva Froňková, Kateřina Zdráhalová, Tomáš Kalina, Jaroslav Štěrba, Y. Jabali, Vladimír Mihál, Bohumír Blažek, Zuzana Černá, Dagmar Procházková, Jiří Hák, Zuzana Zemanová, Marie Jarošová, Alexandra Oltová, Petr Sedláček, J. Schwarz, Jan Zuna, Jan Trka, Jan Starý, Ondřej Hrušák
منشور في 2010Artigo
أدوات البحث:
موضوعات ذات صلة
Biology
Genetics
Medicine
Leukemia
Gene
Immunology
Internal medicine
Oncology
Cancer research
Lymphoblastic Leukemia
Minimal residual disease
Myeloid leukemia
Chromosomal translocation
Myeloid
Acute lymphocytic leukemia
Flow cytometry
Acute leukemia
Bone marrow
Breakpoint
Chromosome
ETV6
Fusion gene
Gene expression
Gene rearrangement
Haematopoiesis
Immunophenotyping
Molecular biology
Phenotype
Risk stratification
Stem cell